Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding with ibrutinib treatment. Our study sought to describe the i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Wiczer, Tracy E., Levine, Lauren B., Brumbaugh, Jessica, Coggins, Jessica, Zhao, Qiuhong, Ruppert, Amy S., Rogers, Kerry, McCoy, Anli, Mousa, Luay, Guha, Avirup, Heerema, Nyla A., Maddocks, Kami, Christian, Beth, Andritsos, Leslie A., Jaglowski, Samantha, Devine, Steven, Baiocchi, Robert, Woyach, Jennifer, Jones, Jeffrey, Grever, Michael, Blum, Kristie A., Byrd, John C., Awan, Farrukh T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728342/
https://ncbi.nlm.nih.gov/pubmed/29296820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009720
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados